Microbiota and mycobiota in chronic inflammatory demyelinating polyneuropathy: clinical and pathophysiological

Szymon Andrusiów1, Anita Brzoza2, Piotr Łacina3

  • 1Department of Neurology, Faculty of Medicine, University Centre of Neurology and Neurosurgery, Wrocław Medical University, Wrocław, Poland.

Abstract

Insights

This study found increased gut bacteria diversity in Chronic Inflammatory Demyelinating Polyneuropathy (CIDP) patients, correlating with disease severity and nerve damage. Microbiome and fungal alterations were observed, offering potential new biomarkers for CIDP.

Area of Science:

  • Neurology
  • Microbiology
  • Immunology

Background:

  • Chronic inflammatory demyelinating polyneuropathy (CIDP) is an immune-mediated neuropathy with unknown triggers and no validated biomarkers.
  • Investigating the gut microbiome and its relationship with immune responses is crucial for understanding CIDP pathogenesis.

Purpose of the Study:

  • To investigate associations between bacterial and fungal communities, short-chain fatty acids (SCFAs), and IL18 promoter variation in CIDP patients.
  • To correlate these factors with clinical and electrophysiological measures of disease severity.

Main Methods:

  • 32 treatment-naive CIDP patients and 15 healthy controls were enrolled.
  • Stool, serum, and cerebrospinal fluid (CSF) samples were analyzed for microbiota, mycobiota, and SCFAs.
  • IL18 promoter variants were genotyped, and disability was assessed using clinical scales and nerve conduction studies (NCS).

Main Results:

  • CIDP patients exhibited increased fecal bacterial alpha diversity and significant beta diversity shifts compared to controls.
  • Higher fecal bacterial diversity correlated with greater NCS abnormalities.
  • Specific bacterial taxa were enriched or depleted in CIDP, and SCFA concentrations correlated with bacterial diversity.

Conclusions:

  • The study confirms increased gut microbiome alpha diversity in CIDP patients.
  • Significant alterations in gut microbiota and mycobiota are associated with CIDP and correlate with clinical and electrophysiological parameters.

Related Concept Videos

Inflammatory Bowel Disease III: Crohn's Disease01:25

Inflammatory Bowel Disease III: Crohn's Disease

Crohn’s disease is a chronic, relapsing form of inflammatory bowel disease characterized by segmental, transmural inflammation that can affect any part of the gastrointestinal tract. Its pathogenesis arises from a combination of genetic susceptibility, environmental exposures, epithelial barrier dysfunction, and immune dysregulation. Together, these factors lead to an exaggerated immune response against components of the gut microbiome.Genetic and Environmental InfluencesMultiple genetic...
Dysbiosis of the Gut Microbiota01:18

Dysbiosis of the Gut Microbiota

The human gut microbiome includes a diverse array of microbial species, including beneficial commensals and opportunistic pathogens, which interact to support host health. These microbes contribute to essential functions such as nutrient metabolism, immune system modulation, and maintenance of intestinal barrier integrity. However, disruptions to this equilibrium—referred to as dysbiosis—can have widespread physiological consequences.Dysbiosis is often characterized by reduced microbial...
Fungal Phylum Microsporidia01:28

Fungal Phylum Microsporidia

Microsporidia are a group of obligate intracellular fungi that were initially classified as protists but were later reclassified based on phylogenetic, molecular, and structural evidence linking them to the Chytridiomycota. These unicellular, non-motile organisms are highly specialized parasites that infect a wide range of animal hosts, including humans. They have evolved extensive genomic and metabolic reductions, making them highly dependent on their hosts for survival.Morphology and Genomic...
Inflammatory Bowel Disease II: Ulcerative Colitis01:20

Inflammatory Bowel Disease II: Ulcerative Colitis

Ulcerative colitis is a chronic inflammatory disorder of the colon characterized by continuous mucosal inflammation that typically begins in the rectum and extends proximally in a uniform pattern. Its pathogenesis involves a complex interplay of genetic predisposition, immune dysregulation, and environmental influences. These factors converge to impair the colon’s epithelial defenses and promote an exaggerated inflammatory response against luminal contents.Breakdown of the Mucosal BarrierA...
Chronic Pancreatitis II: Pathophysiology01:21

Chronic Pancreatitis II: Pathophysiology

Chronic pancreatitis is a progressive and irreversible inflammation of the pancreas, most often caused by long-term alcohol abuse, but it can also be related to ductal obstruction, smoking, or genetic factors.Chronic pancreatitis occurs when the pancreas is repeatedly exposed to harmful agents like alcohol, smoking, ductal obstruction, or genetic predisposition. These factors lead to the release of toxic metabolites and inflammatory cytokines, sustaining chronic inflammation in the pancreatic...